CVS Health Corp. Financial Ratios — CVS Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	16.71	16.4	17.16	15.38	15.54	14.27	11.55	-0.73	7.48	7.67	8.06	4.17	7.76	4.14	1.58
Return on Assets (%)	5.46	5.91	6.67	6.37	6.29	5.69	6.99	-0.41	3.17	3.17	3.45	1.87	3.49	1.83	0.7
Return on Capital (%)	12.42	12.57	12.79	11.57	10.68	9.23	8.83	-1.3	5.21	5.14	5.5	3.38	5.64	3.55	2.24
Return on Invested Capital (%)	8.02	9.26	9.94	10.42	9.96	9.92	12.08	-4.38	6.32	6.66	7.48	8.22	7.33	4.6	5.35
Gross Margin (%)	19.2	18.27	18.76	18.2	17.31	16.24	15.44	16.21	17.73	18.25	17.84	16.9	15.21	13.79	13.77
EBITDA Margin (%)	7.38	7.28	7.82	7.7	7.55	7.24	6.6	6.62	6.46	6.83	6.7	6.36	5.3	3.83	3.73
Operating Margin (%)	5.91	5.86	6.34	6.31	6.18	5.85	5.26	5.23	4.76	5.18	5.17	5.05	4.08	2.6	2.58
Incremental Operating Margin (%)	1.72	5.48	22.71	6.04	4.86	3.76	-9.21	4.61	3.29	14.19	5.08	3.92	-4.79	-32.62	2.36
Pretax Margin (%)	5.37	5.12	5.94	5.51	5.62	4.86	4.47	0.72	3.5	3.64	3.61	1.81	3.12	1.65	0.53
Profit Margin (%)	3.23	3.14	3.62	3.33	3.42	2.99	3.58	-0.31	2.58	2.67	2.74	1.34	2.33	1.24	0.44
Net Income to Common Margin (%)	3.23	3.14	3.62	3.33	3.42	2.99	3.58	-0.31	2.58	2.67	2.74	1.34	2.33	1.24	0.44
Effective Tax Rate (%)	39.29	38.64	38.89	39.5	39.3	38.4	19.8	142.39	26.3	26.29	24.18	25.86	25.11	25.41	19.1
Dvd Payout Ratio (%)	19.34	21.44	23.85	27.73	30.12	34.57	30.9	-340.8	39.27	36.37	32.91	66.94	37.32	74	201.24
Sustainable Growth Rate (%)	13.48	12.88	13.07	11.12	10.86	9.34	7.98	-3.23	4.54	4.88	5.41	1.38	4.86	1.08	-1.6

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	10,014	9,828	13,402	12,890	27,464	27,531	27,002	73,429	89,002	85,042	75,999	70,732	79,385	82,920	79,950
ST Debt	806	695	561	1,260	1,197	1,916	4,821	1,985	5,377	7,078	5,851	3,456	4,713	7,494	5,805
LT Debt	9,208	9,133	12,841	11,630	26,267	25,615	22,181	71,444	83,625	77,964	70,148	67,276	74,672	75,426	74,145
Total Debt/EBITDA	1.27	1.1	1.35	1.2	2.37	2.14	2.21	5.7	5.37	4.63	3.88	3.45	4.19	5.8	5.33
Net Debt/EBITDA	1.09	0.94	0.94	0.97	2.16	1.88	2.07	5.38	3.79	3.09	2.39	1.92	2.82	4.04	3.74
Total Debt/EBIT	1.58	1.36	1.67	1.46	2.9	2.65	2.78	7.22	7.28	6.11	5.03	4.34	5.44	8.55	7.7
Net Debt/EBIT	1.36	1.17	1.16	1.18	2.64	2.33	2.6	6.82	5.14	4.08	3.1	2.41	3.66	5.95	5.4
EBITDA to Interest Expense	13.43	15.98	19.16	17.45	13.47	11.93	11.49	4.92	5.47	6.31	7.82	8.97	7.14	4.83	4.81
EBITDA-CapEx/Interest Expense	10.25	12.36	15.32	13.97	10.71	9.87	9.68	4.14	4.66	5.47	6.82	7.78	5.99	3.89	3.9
EBIT to Interest Expense	10.77	12.85	15.55	14.31	11.03	9.63	9.15	3.88	4.03	4.79	6.03	7.12	5.49	3.28	3.33
Interest Expense	588	561	517	615	859	1,078	1,062	2,619	3,035	2,907	2,503	2,287	2,658	2,958	3,119
Common Equity/Total Assets	34.25	37.78	39.86	42.95	38.43	41.29	79.52	43.95	40.94	41.68	43.9	45.82	44.29	44.43	44.02
Long-Term Debt/Equity (%)	24.2	24.26	33.85	30.64	70.6	69.54	58.84	122.04	130.32	111.85	93.06	93.74	97.44	99.6	98.36
Long-Term Debt/Capital (%)	28.64	26.21	30.64	25.98	41.7	38.5	21.61	44.63	46.36	42.95	39.28	38.31	39.27	38.56	38.67
Long-Term Debt/Total Assets (%)	14.27	13.79	17.95	15.68	28.42	27.12	23.32	36.37	37.59	33.79	30.11	29.47	29.9	29.79	29.24
Total Debt/Equity (%)	26.32	26.1	35.33	33.95	73.82	74.74	71.63	125.43	138.7	122.01	100.82	98.56	103.59	109.49	106.06
Total Debt/Capital (%)	31.15	28.21	31.98	28.8	43.6	41.38	26.3	45.87	49.34	46.85	42.56	40.27	41.75	42.4	41.7
Total Debt/Total Assets (%)	15.52	14.84	18.74	17.38	29.71	29.15	28.38	37.38	40.01	36.86	32.62	30.99	31.79	32.75	31.53
Net Debt to Equity	22.6	22.45	24.55	27.42	67.21	65.59	67.13	118.49	97.86	81.48	62.04	54.77	69.7	76.17	74.44
Net Debt/Capital (%)	27.98	25.26	24.62	24.62	41.31	38.25	25.06	44.46	35.94	32.7	27.64	24.16	29.35	30.85	30.62
EBITDA	7,899	8,963	9,907	10,730	11,567	12,861	12,198	12,888	16,589	18,352	19,585	20,514	18,965	14,292	14,991
EBITDA-CapEx	6,027	6,933	7,923	8,594	9,200	10,637	10,280	10,851	14,132	15,915	17,065	17,787	15,934	11,511	12,159
Operating Income (Loss)	6,331	7,210	8,037	8,799	9,475	10,386	9,719	10,170	12,218	13,911	15,099	16,290	14,599	9,695	10,385

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.12	0.1	0.27	0.13	0.11	0.13	0.06	0.15	0.15	0.18	0.18	0.23	0.14	0.13	0.12
Current Ratio	1.56	1.42	1.64	1.37	1.26	1.18	1.02	1.03	0.94	0.91	0.88	0.95	0.86	0.81	0.84
Quick Ratio	0.62	0.56	0.84	0.64	0.62	0.6	0.49	0.55	0.52	0.53	0.55	0.62	0.59	0.56	0.57
CFO/Avg Current Liab	0.51	0.51	0.39	0.47	0.4	0.41	0.28	0.24	0.26	0.28	0.28	0.24	0.18	0.11	0.12
Common Equity/Total Assets	34.25	37.78	39.86	42.95	38.43	41.29	79.52	43.95	40.94	41.68	43.9	45.82	44.29	44.43	44.02
Long-Term Debt/Equity (%)	24.2	24.26	33.85	30.64	70.6	69.54	58.84	122.04	130.32	111.85	93.06	93.74	97.44	99.6	98.36
Long-Term Debt/Capital (%)	28.64	26.21	30.64	25.98	41.7	38.5	21.61	44.63	46.36	42.95	39.28	38.31	39.27	38.56	38.67
Long-Term Debt/Total Assets (%)	14.27	13.79	17.95	15.68	28.42	27.12	23.32	36.37	37.59	33.79	30.11	29.47	29.9	29.79	29.24
Total Debt/Equity (%)	26.32	26.1	35.33	33.95	73.82	74.74	71.63	125.43	138.7	122.01	100.82	98.56	103.59	109.49	106.06
Total Debt/Capital (%)	31.15	28.21	31.98	28.8	43.6	41.38	26.3	45.87	49.34	46.85	42.56	40.27	41.75	42.4	41.7
Total Debt/Total Assets (%)	15.52	14.84	18.74	17.38	29.71	29.15	28.38	37.38	40.01	36.86	32.62	30.99	31.79	32.75	31.53
CFO/Total Liabilities	22.1	23.35	17.22	22.46	15.46	17.6	13.94	6.43	8.12	9.85	11.59	10.34	7.76	5.13	5.97
CFO/CapEx	3.13	3.29	2.91	3.81	3.61	4.56	4.17	4.35	5.23	6.51	7.25	5.93	4.43	3.27	3.76
Altman's Z-Score	7.15	7.58	7.34	7.95	7.16	7.25	7.24	3.83	3.62	3.48	3.8	4.06	4.06	3.71	3.88

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	19.52	19.66	16.67	15.14	14.21	14.76	18.4	23.33	28.32	28.12	28.92	29.15	26.23	24.66	26
Days Sales Outstanding	18.7	18.57	21.9	24.12	25.69	24.72	19.84	15.65	12.89	12.98	12.62	12.52	13.92	14.8	14.04
Inventory Turnover	8.34	9.55	9.33	9.92	9.78	10.34	10.4	10.27	12.44	12.2	13.24	14.54	16.35	17.79	18.56
Days Inventory Outstanding	43.75	38.23	39.13	36.78	37.33	35.3	35.1	35.53	29.34	29.92	27.57	25.1	22.33	20.52	19.66
Accounts Payable Turnover	20.45	21.53	19.4	19	18.36	19.37	18.66	18.46	21.87	20.4	20.21	19.67	20.33	20.88	20.75
Accounts Payable Turnover Days	17.84	16.95	18.82	19.21	19.88	18.85	19.56	19.77	16.69	17.89	18.06	18.56	17.95	17.48	17.59
Cash Conversion Cycle	44.61	39.84	42.21	41.68	43.13	41.17	35.38	31.41	25.54	25.01	22.13	19.06	18.29	17.84	16.11
Inventory to Cash Days	-25.05	-19.66	-17.23	-12.66	-11.65	-10.57	-15.26	-19.89	-16.45	-16.94	-14.95	-12.57	-8.41	-5.72	-5.62
Inventories	10,046	11,032	11,045	11,930	14,001	14,760	15,296	16,450	17,516	18,496	17,760	19,090	18,025	18,107	19,246
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	10,046	11,032	11,045	11,930	14,001	14,760	15,296	16,450	17,516	18,496	17,760	19,649	18,632	18,107	19,246

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	54,564	61,453	87,101	111,816	109,307	84,670	73,950	68,403	96,651	89,405	136,068	122,265	101,464	56,517	100,549
- Cash & Cash Equivalents	1,413	1,375	4,089	2,481	2,459	3,371	1,696	4,059	5,683	7,854	9,408	12,945	8,196	8,586	8,453
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	30	- -	- -	5	7	4	4	318	306	312	306	300	175	170	168
+ Total Debt	10,014	9,828	13,402	12,890	27,464	27,531	27,002	73,429	89,002	85,042	75,999	70,732	79,385	82,920	79,950
Enterprise Value	63,190	69,901	96,326	122,196	134,231	108,747	99,149	135,569	177,903	163,905	199,848	177,574	169,569	128,614	170,069
Total Capital	32,150	34,843	41,912	44,761	62,994	66,535	102,658	160,098	180,388	181,507	178,588	175,623	190,156	195,588	191,716
Total Debt/Capital (%)	31.15	28.21	31.98	28.8	43.6	41.38	26.3	45.87	49.34	46.85	42.56	40.27	41.75	42.4	41.7
Total Debt / EV	0.16	0.14	0.14	0.11	0.2	0.25	0.27	0.54	0.5	0.52	0.38	0.4	0.47	0.64	0.47
EV/Sales	0.59	0.57	0.76	0.88	0.88	0.61	0.54	0.7	0.69	0.61	0.68	0.55	0.47	0.34	0.42
EV/EBITDA	8	7.8	9.72	11.39	11.6	8.46	8.13	10.52	10.72	8.93	10.2	8.66	8.94	9	11.34
EV/EBIT	9.98	9.69	11.99	13.89	14.17	10.47	10.2	13.33	14.56	11.78	13.24	10.9	11.62	13.27	16.38
EV/Cash Flow to Firm	10.17	9.96	15.79	14.36	14.82	10.06	11.19	17.48	11.79	9.1	9.91	9.94	11	11.37	12.92
EV/Free Cash Flow to Firm	7.82	7.73	11.92	11.48	11.75	8.35	9.2	13.85	10.14	8.02	8.81	8.62	9.19	9.13	10.63
Diluted Market Cap	54,931	61,888	87,745	112,586	110,089	85,144	74,240	68,403	96,948	89,746	137,100	123,290	101,858	56,651	100,867
Diluted Enterprise Value	63,562	70,341	97,058	123,000	135,101	109,308	99,550	138,091	180,573	167,246	203,997	181,377	173,222	131,155	172,532
EV per Share	47.23	55	79.15	105.25	120.06	101.35	97.2	129.86	136.74	125.21	151.51	135.35	131.96	102.16	134.23
TTM Sales	107,080	123,120	126,761	139,367	153,290	177,546	184,786	194,579	256,776	268,706	292,111	322,467	357,776	372,809	402,067
TTM EBITDA	7,899	8,963	9,907	10,730	11,567	12,861	12,198	12,888	16,589	18,352	19,585	20,514	18,965	14,292	14,991
TTM Operating Income	6,331	7,210	8,037	8,799	9,475	10,386	9,719	10,170	12,218	13,911	15,099	16,290	14,599	9,695	10,385
TTM Cash Flow to Firm	6,213	7,015	6,099	8,509	9,060	10,805	8,859	7,755	15,085	18,008	20,163	17,873	15,417	11,313	13,162
TTM Free Cash Flow to Firm	8,085	9,045	8,083	10,645	11,427	13,029	10,777	9,792	17,542	20,445	22,683	20,600	18,448	14,094	15,994

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	7.11	7.11	11.3	10.96	10.09	6.89	7.48	6.27	6.33	4.9	6.6	6.52	6.19	4.77	7.49
EV/EBIT	9.98	9.69	11.99	13.89	14.17	10.47	10.2	13.33	14.56	11.78	13.24	10.9	11.62	13.27	16.38
Enterprise Value	63,190	69,901	96,326	122,196	134,231	108,747	99,149	135,569	177,903	163,905	199,848	177,574	169,569	128,614	170,069
Low Price	31.3	41.01	49	64.95	81.37	69.3	66.45	60.14	51.72	52.04	68.02	86.28	64.41	43.56	44.11
EV/Sales	0.59	0.57	0.76	0.88	0.88	0.61	0.54	0.7	0.69	0.61	0.68	0.55	0.47	0.34	0.42
EV/EBITDA	8	7.8	9.72	11.39	11.6	8.46	8.13	10.52	10.72	8.93	10.2	8.66	8.94	9	11.34
Price/Earnings	15.76	15.9	18.97	24.08	20.87	15.92	11.17	- -	14.57	12.45	17.01	28.36	12.16	12.25	56.87
Price/Earnings Average	13.89	14.95	15.52	19.6	21.7	18.78	11.96	-124.65	12.02	11.71	13.66	30.29	11.43	17.24	48.98
Price/Earnings High	15.98	16.38	19.08	24.66	24.26	21.53	13.05	-147.43	15.11	13.94	17.24	33.86	14.39	22.72	61.02
Price/Earnings Low	12.1	13.49	12.99	16.24	17.37	13.99	10.24	-105.7	10.14	9.49	11.21	26.26	9.92	11.89	31.61
Price/Book Value	2.47	2.46	3.06	3.51	3.08	2.17	0.98	0.79	1.06	0.93	1.33	1.17	0.92	0.5	0.9
Price/Book Value Average	2.18	2.31	2.5	2.86	3.2	2.56	1.05	0.86	0.88	0.87	1.07	1.25	0.86	0.71	0.78
Price/Book Value High	2.5	2.53	3.07	3.59	3.58	2.93	1.14	1.01	1.1	1.04	1.35	1.4	1.09	0.93	0.97
Price/Book Value Low	1.89	2.08	2.09	2.37	2.56	1.91	0.9	0.73	0.74	0.71	0.88	1.08	0.75	0.49	0.5
Price/Tangible Book Value	31.65	40.83	46.65	2,379.06	-7.4	-5.67	-5.14	-1.21	-1.98	-2.18	-4.15	-3.92	-2.31	-1.32	-2.82
Price/Tangible Book Value Average	27.89	38.38	38.17	1,936.4	-7.69	-6.69	-5.5	-1.31	-1.64	-2.05	-3.34	-4.19	-2.17	-1.86	-2.43
Price/Tangible Book Value High	32.09	42.06	46.93	2,436.12	-8.6	-7.67	-6.01	-1.55	-2.06	-2.44	-4.21	-4.68	-2.74	-2.45	-3.03
Price/Tangible Book Value Low	24.29	34.63	31.94	1,604.4	-6.15	-4.98	-4.71	-1.11	-1.38	-1.66	-2.74	-3.63	-1.89	-1.28	-1.57
Price/Sales	0.51	0.5	0.69	0.8	0.71	0.48	0.4	0.35	0.38	0.33	0.47	0.38	0.28	0.15	0.25
Price/Sales Average	0.45	0.47	0.56	0.65	0.74	0.56	0.43	0.38	0.31	0.31	0.37	0.4	0.27	0.21	0.22
Price/Sales High	0.52	0.51	0.69	0.82	0.83	0.64	0.47	0.45	0.39	0.37	0.47	0.45	0.34	0.28	0.27
Price/Sales Low	0.39	0.42	0.47	0.54	0.59	0.42	0.37	0.32	0.26	0.25	0.31	0.35	0.23	0.15	0.14
Price/Cash Flow	9.32	9.21	15.06	13.74	12.8	8.35	9.24	7.72	7.52	5.64	7.45	7.56	7.56	6.21	9.45
Price/Cash Flow Average	8.21	8.66	12.32	11.18	13.31	9.85	9.89	8.35	6.21	5.3	5.98	8.07	7.1	8.74	8.14
Price/Cash Flow High	9.45	9.49	15.15	14.07	14.88	11.29	10.79	9.88	7.8	6.31	7.55	9.02	8.94	11.51	10.14
Price/Cash Flow Low	7.15	7.81	10.31	9.27	10.65	7.33	8.46	7.08	5.24	4.29	4.91	7	6.16	6.02	5.25
Price/Free Cash Flow Average	6.26	6.69	9.24	8.92	10.49	8.12	8.01	6.79	5.23	4.61	5.3	6.96	5.82	6.71	6.45
Price/Free Cash Flow High	7.21	7.33	11.36	11.22	11.73	9.31	8.74	8.03	6.57	5.49	6.69	7.79	7.32	8.84	8.03
Price/Free Cash Flow Low	5.46	6.03	7.73	7.39	8.4	6.05	6.86	5.76	4.41	3.74	4.35	6.04	5.05	4.62	4.16
EV/Sales Average	0.53	0.54	0.64	0.73	0.9	0.7	0.57	0.74	0.64	0.6	0.6	0.59	0.47	0.41	0.39
EV/Sales High	0.6	0.58	0.76	0.9	0.99	0.78	0.6	0.81	0.72	0.66	0.7	0.63	0.53	0.48	0.45
EV/Sales Low	0.47	0.49	0.54	0.62	0.76	0.55	0.5	0.68	0.59	0.54	0.54	0.53	0.43	0.35	0.32
EV/EBITDA Average	7.18	7.39	8.13	9.45	11.99	9.64	8.57	11.15	9.85	8.8	9	9.2	8.79	10.78	10.56
EV/EBITDA High	8.1	8	9.78	11.64	13.15	10.78	9.16	12.2	11.08	9.68	10.46	9.95	10.09	12.55	11.98
EV/EBITDA Low	6.39	6.76	6.96	8	10.03	7.66	7.63	10.28	9.1	7.93	8	8.35	8.13	9.05	8.51
EV/EBIT Average	8.96	9.18	10.03	11.53	14.63	11.94	10.75	14.13	13.37	11.62	11.67	11.58	11.42	15.89	15.24
EV/EBIT High	10.1	9.95	12.06	14.2	16.05	13.35	11.5	15.46	15.05	12.76	13.56	12.53	13.11	18.5	17.29
EV/EBIT Low	7.98	8.4	8.58	9.75	12.24	9.49	9.58	13.03	12.35	10.47	10.37	10.51	10.56	13.34	12.28
Last Price	40.78	48.35	71.57	96.31	97.77	78.91	72.5	65.52	74.29	68.3	103.16	93.19	78.96	44.89	79.36
High Price	41.35	49.8	71.99	98.62	113.65	106.67	84.72	83.88	77.03	76.44	104.56	111.25	93.41	83.25	85.15
Enterprise Value Average	56,720	66,216	80,574	101,425	138,655	124,006	104,504	143,729	163,357	161,582	176,172	188,651	166,753	154,064	158,265
Enterprise Value High	63,957	71,749	96,925	124,912	152,073	138,621	111,724	157,259	183,841	177,560	204,812	204,047	191,396	179,316	179,550
Enterprise Value Low	50,510	60,577	68,946	85,821	115,984	98,523	93,089	132,474	150,913	145,620	156,615	171,286	154,131	129,346	127,552

Shares Outstanding	1,298	1,231	1,180	1,140	1,101	1,061	1,014	1,295	1,302	1,310	1,322	1,300	1,288	1,260	1,271
Diluted Weighted Avg Shares	1,347	1,280	1,226	1,169	1,126	1,079	1,024	1,044	1,305	1,314	1,329	1,323	1,290	1,262	1,271
Basic Weighted Avg Shares	1,338	1,271	1,217	1,161	1,118	1,073	1,020	1,044	1,301	1,309	1,319	1,312	1,285	1,259	1,267
Revenue per Share	80.03	96.87	104.16	120.04	137.11	165.47	181.16	186.38	197.37	205.28	221.46	245.78	278.42	296.12	317.34
EBITDA per Share	5.9	7.05	8.14	9.24	10.35	11.99	11.96	12.34	12.75	14.02	14.85	15.64	14.76	11.35	11.83
Operating Income per Share	4.73	5.67	6.6	7.58	8.47	9.68	9.53	9.74	9.39	10.63	11.45	12.42	11.36	7.7	8.2
Basic EPS, GAAP	2.59	3.04	3.77	4	4.68	4.96	6.49	-0.57	5.1	5.48	6.07	3.29	6.49	3.66	1.4
Basic EPS from Cont Ops	2.61	3.04	3.78	4	4.68	4.96	6.5	-0.57	5.1	5.5	6.06	3.3	6.51	3.64	1.36
Diluted EPS, GAAP	2.57	3.02	3.75	3.97	4.65	4.93	6.47	-0.57	5.08	5.46	6.02	3.26	6.47	3.66	1.39
Diluted EPS from Cont Ops	2.59	3.02	3.75	3.97	4.64	4.93	6.48	-0.57	5.08	5.48	6.01	3.27	6.49	3.63	1.36
Dividend per Share	0.5	0.65	0.9	1.11	1.41	1.71	2.01	1.95	2	2	1.99	2.22	2.44	2.68	2.68
Cash Flow per Share	4.38	5.25	4.75	7.01	7.64	9.45	7.85	8.49	9.88	12.12	13.85	12.33	10.45	7.23	8.4
Free Cash Flow per Basic Share	2.98	3.65	3.12	5.17	5.52	7.38	5.97	6.54	7.99	10.26	11.94	10.25	8.09	5.02	6.16
Cash & Equivalents per Share	1.06	1.09	3.43	2.17	2.28	3.22	1.77	6.3	6.19	8.29	9.5	11.98	8.91	8.73	8.36
Book Value per Share	16.52	19.68	23.43	27.45	31.77	36.35	74.17	82.71	70.01	73.46	77.55	79.72	86.07	89.36	88.08
Tangible Book Value per Share	1.29	1.18	1.53	0.04	-13.22	-13.91	-14.1	-54.27	-37.43	-31.32	-24.84	-23.77	-34.14	-34.05	-28.1

CVS Health Corp.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)